Navigation Links
Synvista Therapeutics to Present at the 10th Annual BIO CEO & Investor Conference
Date:2/6/2008

- Presentation to be Webcast -

MONTVALE, N.J., Feb. 6 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. (Amex: SYI) announced today that Noah Berkowitz, M.D., Ph.D., President and Chief Executive Officer of Synvista will present at the upcoming 10th Annual BIO CEO & Investor Conference on Monday, February 11, 2008 at 3:30 p.m. Eastern Time. The event will be held from February 11 - 13, 2008 at the Waldorf-Astoria Hotel in New York City.

Dr. Berkowitz will discuss the company's planned and/or ongoing Phase 2 initiatives for ALT-2074 in cardiovascular diseases and psoriasis, and alagebrium in heart failure and diabetic nephropathy. He will also provide an update of recent milestones.

The presentation will be simultaneously webcast and can be viewed live on the investor relations section of the Company's website at http://www.synvista.com. Participants are encouraged to log on to the webcast approximately five to ten minutes prior to the start of the presentation. It will be archived there after the event.

Note to Attendees: Synvista will be available for one-on-one meetings. Please arrange through BIO or by calling Kim Sutton Golodetz at Lippert/Heilshorn & Associates at 212-838-3777.

About Synvista Therapeutics

Synvista Therapeutics is a biopharmaceutical company developing small molecule drugs to treat and prevent cardiovascular disease and to treat nephropathy in people with diabetes. The Company has identified several product candidates that it believes represent novel approaches to some of the largest pharmaceutical markets. The Company's portfolio includes orally bioavailable, organoselenium mimics of glutathione peroxid
'/>"/>

SOURCE Synvista Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Synvista Therapeutics to Develop Topical Formulation of ALT-2074 for the Treatment of Psoriasis
2. Synvista Therapeutics to be Featured on Wallst.net
3. Synvista Therapeutics to Present at the BIO InvestorForum 2007
4. Cell Therapeutics, Inc. (CTI) to Present at 10th Annual BIO CEO & Investor Conference
5. Nile Therapeutics, Inc. to Present at Upcoming BIO CEO & Investor Conference
6. Halozyme Therapeutics to Present at the BIO CEO and Investor Conference and the Roth Growth Stock Conference
7. Echo Therapeutics to Present at RedChip Small-Cap Investor Conference
8. CV Therapeutics and Medlogics Device Corporation Sign Licensing Agreement for CVTs Innovative Stent Coating Technology
9. Velcura Therapeutics, Inc. Teams with International Discovery Sourcing Consultants to Develop New Therapeutic Molecules for Cancer and Bone Disease
10. Synosia Therapeutics Appoints Chief Financial Officer to New Company Headquarters in Switzerland
11. Taligen Therapeutics Secures Series B Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)...UEBEC CITY, Dec. 4 /PRNewswire-FirstCall/ - AEtern...bal biopharmaceutical company focused on endocrine...esident and CEO, Juergen Engel, Ph.D., will take p...ainstay With Newer And Better Agents" at the upcom... on Wednesday, December 10, 2008 at 4:30 pm (easte...
(Date:12/4/2008)... Applied Biosystems, part ...provider of innovative life science research and d...ology for next-generation genomic analysis, the SO... Innovation of the Year for 2008 by The Scientist,...ife science industry. In making the announcement o...
(Date:12/4/2008)...OTHELL, WA, and VANCOUVER, Dec. 4 /PRNewswire-Firs... OGXI ) will participate on the ,Waging a Battle A...08 Healthcare Conference on Thursday, December 11 ...New York. During the panel discussion, OncoGenex, ...ck, will provide a brief overview of the company,s...
(Date:12/3/2008)...LYMOUTH, Minn., Dec. 3 e...device company, today announced the appointment of...ve immediately. , Mr. Miclot is currently t...edical, a privately held nationwide provider of va...h as diabetes, wound care, urology and respiratory...
Breaking Biology Technology: Applied Biosystems SOLiD System Named Life Science Innovation of the Year : The Scientist Magazine Cites the Technology's High Throughput, Lower Sequencing Cost, and Rapid Technology Innovation for Unlocking New Approaches to Clinical Research 2 Applied Biosystems SOLiD System Named Life Science Innovation of the Year : The Scientist Magazine Cites the Technology's High Throughput, Lower Sequencing Cost, and Rapid Technology Innovation for Unlocking New Approaches to Clinical Research 3 Applied Biosystems SOLiD System Named Life Science Innovation of the Year : The Scientist Magazine Cites the Technology's High Throughput, Lower Sequencing Cost, and Rapid Technology Innovation for Unlocking New Approaches to Clinical Research 4 Applied Biosystems SOLiD System Named Life Science Innovation of the Year : The Scientist Magazine Cites the Technology's High Throughput, Lower Sequencing Cost, and Rapid Technology Innovation for Unlocking New Approaches to Clinical Research 5ev3 Inc. Appoints John L. Miclot to Board of Directors 2
...son, Wis. - University of Wisconsin-Madison res...$20 million grant from the National Institutes of.... , ,The grant is part of a $300 million fund for ...ted by the NIH in 2000 to develop techniques and t...n,s Center for Eukaryotic Structural Genomics is...
...ford, Wis. - API Software, Inc. announced today... contracts to purchase multiple components of the ...82, API has more than 400 installations in the Uni...0 employees to more than 30,000 employees. , ,Hosp..., St. Alexius Medical Center -- Bismarck, N.D. , S...
...ICAGO Its that time again for the half-year roun...the U.S. life sciences sector. If you recall the r...l for the major indices: , , Dow Jones down 3 perc...aq Biotech down 16% percent , Amex Biotech down 9 ... below, the results for the first six months of 20...
Are you finding it harder to resist the use of e-mail on vacation or the weekend? According to a recent study by AOL, 60 percent of respondents check email while on vacation. Most people check their
Other Biology Technology:UW-Madison awarded $20 million grant for protein research 2UW-Madison awarded $20 million grant for protein research 3Midwest large cap life sciences mostly outperform market 2Midwest large cap life sciences mostly outperform market 3
(Date:12/3/2008)...ember 3, 2008. The first 5-year forest inventory r... available to the public: Oregon,s Forest Resource...sis Report. , Here are some key findings from th...lion acres; about half of Oregon,s total land area...erted to other uses particularly near urban areas....
(Date:12/3/2008)...ripps Institution of Oceanography at UC San Diego ... captured unprecedented details of vibrant sea lif...ing documentations of new species and marine anima...s, which included surveys at unexplored depths, ha...tions and evidence that human impacts have stretch...
(Date:12/3/2008)...us to insert a corrective gene into mouse blood ce...spital have alleviated sickle cell disease patholo...he treated mice showed essentially no difference f...hat applying the gene therapy to humans presents s...the new therapy will become an important treatment...
(Date:12/3/2008)...n has demonstrated how a technique using lasers co...tmosphere. The campaign supports one of the main o...mission. , A-SCOPE (Advanced Space Carbon and cl...ix candidate Earth Explorer missions that has just...along with the other five, will be presented to th...
Breaking Biology News(10 mins):Forest inventories in Oregon include more than trees 2Forest inventories in Oregon include more than trees 3Expeditions reveal gulf of California's deep sea secrets, as well as human imprints 2Expeditions reveal gulf of California's deep sea secrets, as well as human imprints 3Expeditions reveal gulf of California's deep sea secrets, as well as human imprints 4Gene therapy corrects sickle cell disease in laboratory study 2Gene therapy corrects sickle cell disease in laboratory study 3ESA tests laser to measure atmospheric carbon dioxide 2ESA tests laser to measure atmospheric carbon dioxide 3Presentation at ISSN Highlights Soy Protein Advantages for Endurance Athletes 6423 1Presentation at ISSN Highlights Soy Protein Advantages for Endurance Athletes 6423 2Canary Foundation and the Thomas G Labrecque Foundation Launch a New Lung Cancer Early Detection Initiative 6421 1Canary Foundation and the Thomas G Labrecque Foundation Launch a New Lung Cancer Early Detection Initiative 6421 2Canary Foundation and the Thomas G Labrecque Foundation Launch a New Lung Cancer Early Detection Initiative 6421 3Canary Foundation and the Thomas G Labrecque Foundation Launch a New Lung Cancer Early Detection Initiative 6421 4Andy Ambrose Joins MassMutuals Institutional Sales Team for Retirement Services 6419 1Health Fitness Announces Non Cash Adjustment and Restatement of 2006 Equity Investment Transaction Resulting in Delay for Filing Third Quarter Form 10 6417 1Health Fitness Announces Non Cash Adjustment and Restatement of 2006 Equity Investment Transaction Resulting in Delay for Filing Third Quarter Form 10 6417 2
...ity and pediatric specialists at Baylor College of...famed buckyball nanoparticles as passkeys that all...pears in the Jan. 21 issue of the journal Organic ...defend themselves by walling off the outside world...on around the cell,s inner machinery and its DNA b...
... teeth of ancient cave bears, researchers have bee...ion of the bears inhabiting a European valley in t...he ability of DNA sequence analysis to reveal aspe...ast and potentially illuminate the influence of hu...ew work, reported by a collaborative group of rese...
...the uptake of biodiesel will not make any differen... in greater emissions of greenhouse gases than fro...he conclusion of a new study reported today in Che... Analysts at SRI Consulting compared the emissions... overall life cycles from production to combustion...
... of human papillomavirus responsible for most cerv...y uses a cervical scraping, like that for a liquid... responsible for 70 percent of cervical cancers, s... and director of the Gynecologic Cancer Prevention...ata from a National Cancer Institute trial shows t...
Other Biology News:Buckyballs used as 'passkey' into cancer cells 2DNA analysis reveals rapid population shift among Pleistocene cave bears 2Biodiesel won't drive down global warming 2New test for most virulent HPV strains under study 2New test for most virulent HPV strains under study 3
This buffer is Specifically formulated to be used with Endogen's Poly-HRP Streptavidin
...nce FLA-7000 excels at fluorescent and radioisotop...gel documentation. It features four easy-to-access... filter for Imaging Plates) for upgrading flexibil...le choice of four kinds of excitation laser beams....
The Microarray Gene Frame® has been specifically designed for microarray slide hybridisations. These frames feature the same dual strength adhesive system as our standard Gene Frame® range
... and Labeling Kit generates labeled cDNA for use i...dified cDNA is made via a reverse transcription fr...e other methods, there are no unnatural modified n...ion. This unmodified cDNA is then labeled in a one...
Biology Products: